Integrated Biologic Discovery, Built for Decision Confidence
Mosaic provides integrated biologics discovery services spanning antibody discovery, protein engineering, cell-based assays, protein sciences, and pharmacology. Select a capability area to explore Mosaic’s scientific approach, workflows, and support for candidate identification and advancement. Learn more about our integrated discovery approach and how Mosaic partners with teams to advance biologics programs.
Biologic Discovery Solutions
These solution areas can be engaged independently or combined into an integrated discovery program. Select a category to learn more about our approach, typical workflows, and how we support candidate selection and advancement.
Antibody Discovery & Optimization
Integrated in vitro and in vivo discovery workflows using high-throughput screening, molecular engineering, and functional characterization to identify and optimize therapeutic antibody candidates.
Protein Design & Engineering
Computational and experimental protein engineering platforms enable rational design, optimization, and developability assessment of therapeutic proteins. Mosaic integrates in silico modeling with expression, screening, and biophysical characterization to advance engineered protein therapeutics.
Cell-Based Assays
Fit-for-purpose cell-based assay development supports functional characterization, mechanism-of-action studies, and potency evaluation of biologic therapeutics. Mosaic designs and validates physiologically relevant cellular models to enable confident candidate selection.
Protein Sciences & Analytics
Comprehensive protein characterization and developability assessment support biologic candidate selection and optimization. Mosaic integrates biophysical analysis, stability testing, and advanced analytical workflows to evaluate structure, function, and manufacturability of protein therapeutics.
Pharmacology
Translational pharmacology studies evaluate efficacy, mechanism of action, and in vivo activity of biologic therapeutics. Mosaic designs and executes preclinical pharmacology models to support candidate validation and advancement toward clinical development.
Programs Across Diverse Biologic Modalities and Targets
Mosaic has supported discovery and engineering programs spanning antibodies, multispecifics, engineered proteins, and complex biologic modalities across oncology, immunology, ophthalmology, and rare disease targets. Our discovery capabilities enables seamless progression from early discovery through candidate selection with consistent scientific continuity.
r
End-to-end Biologic Discovery Capabilities
Mosaic supports biologic programs from early discovery through preclinical candidate selection. Our integrated capabilities span antibody discovery, protein engineering, cell-based functional assays, protein analytics, and in vivo pharmacology, enabling seamless progression from concept to validated therapeutic candidates. Teams can engage individual services or deploy Mosaic’s full discovery platform to accelerate biologic development with consistent scientific continuity.
Get Started
Start a conversation with our scientific team about your biologic discovery program.